All Activity

A doctor has been accused of examining patients with blood-stained gloves. Dr Syeda Siddiqui is due to face a misconduct tribunal after being investigated by the General Medical Council (GMC), which regulates the register of doctors able to practise in the UK. Dr Siddiqui is alleged to have examined two patients on 7 August 2024 at the Community Health and Eyecare Ltd Clinic (CHEC) in Warrington, Cheshire, with non-sterile gloves contaminated with the blood of a previous patient. She also faces a similar allegation that she examined a patient at CHEC's Stockport clinic on 10 December 2024 with non-sterile, contaminated gloves. Dr Siddiqui had been carrying out "minor operations" on other patients prior to the incidents outlined. The GMC also alleged that Dr Siddiqui, who qualified from the University of Manchester in 1984, collected used, non-sterile equipment to take home. A notice of the hearing stated the doctor claimed that it was "normal practice" at another CHEC branch when she knew that was untrue. Read full story Source: BBC News, 13 October 2026

Women with autoimmune conditions are up to 74% more likely than men to be told their symptoms are psychological or psychosomatic, and face much longer waits for a diagnosis and treatment, a study suggests. Hundreds of millions of people – about one in 10 globally – are affected by autoimmune conditions, which can cause a range of health issues including fatigue, muscle pain and rashes. But research by the University of Cambridge and University of East Anglia suggests a stark gender divide when it comes to how signs of the conditions are handled by doctors. Women are more likely to have their conditions wrongly attributed to psychiatric causes, more likely to have symptoms misdiagnosed as psychosomatic, and more likely to experience delays in getting a diagnosis, according to the study. The lead author, Melanie Sloan, said: “The damage caused to women by these types of misdiagnosis can be very long lasting in terms of trusting doctors and their own self-esteem.” Sloan, a researcher in the department of public health and primary care at Cambridge and UEA, said some women were forced to wait years before finally getting a diagnosis, causing long delays to treatment for their condition. Read full story Source: The Guardian, 13 October 2026

The transfer of a children’s cancer service, ordered after years of safety concerns, has been delayed again and will not happen before 2028. Guy’s and St Thomas’ Foundation Trust, which is due to run a new centralised paediatric principal treatment centre at the Evelina London Children’s Hospital in Lambeth, said essential approvals from the Building Safety Regulator were “taking more time than originally anticipated”. When NHS England London confirmed the switch in 2024 – which will replace a current service led from the Royal Marsden site in Sutton – it said it would take place from “October 2026 at the earliest”. That date later slipped to March 2027. Papers for the Royal Marsden FT’s board meeting on 30 September said GSTT now expected the transfer in “February or March 2028 at the earliest”. The Marsden’s board was asked to endorse its position that the transfer “cannot safely proceed” without confirmed estates readiness, specialist air-filtered rooms, diagnostic arrangements, and funding for the workforce and the transition period. It was also asked to back continued escalation through NHSE London’s regional oversight board. The PTC for children aged one to 15 in south London, Kent, Surrey, and Sussex is currently run from the Marsden’s Sutton site, which has no paediatric intensive care unit. Children who need intensive care are transferred to St George’s Hospital in Tooting. The Marsden’s papers said such transfers averaged seven a year. A 2019 HSJ investigation revealed that multiple unpublished reviews had found the model unsatisfactory, and that it had been implicated in a series of incidents and child deaths. Concerns had been an “open secret” for almost a decade, one informed figure said at the time. Read full story (paywalled) Source: HSJ, 13 October 2026

Kelly O'Shea says she has woken from more than one operation to be told adequate resources were not available to do the procedure she needed. The 32-year-old, who lives with chronic pain, felt there was no alternative but to pay £20,000 for the endometriosis treatment she needed, out of frustration and desperation. It comes as gynaecologists warn specialist centres in Wales dealing with complex cases of endometriosis are in jeopardy and a national service must be commissioned. The deputy minister for women's health in Wales said the current set up was "not sustainable" and is discussing options for a regional or national service to be established. Changes are being introduced by national accreditation body British Society for Gynaecological Endoscopy (BSGE) highlighting the resource challenges faced by hospitals in Wales. Clinical staff say it has been made worse because of the funding differences between England and Wales. They say unless more resources are found to increase capacity and dedicate teams to endometriosis care, BSGE-accreditation requirements will not be met, which would lead to a downgrading of services, a potential skills exodus and large numbers of patients being sent to England for care. At a recent cross-party Senedd group on women's health, gynaecologists said Wales either needed a nationally commissioned service or an overhaul of the funding model to better reflect the true cost of the specialist care. Read full story Source: BBC News, 12 October 2026

In this 2 minute video, Chief Medical Officer for The UK Sepsis Trust, Ron Daniels explains how antibiotics can enter your food chain, and how this is having an impact on sepsis and antimicrobial resistance. Read the transcript

Preventable harm continues to be a major problem in health care. The WHO estimates the global rate of patient harm is 1 in every 10 patients, and that roughly half of harm is preventable. There has been progress in improving safety over the last quarter century, but rates of patient harm remain high. One reason is that essential patient safety concepts have not been adopted as a central part of professional education and training. We do not expect clinicians to learn anatomy or pharmacology on the job. Why do we expect patient safety can be learned that way? A principal reason for the foot dragging is inertia. Anatomy and chemistry have been the mandatory foundation for medical education for over a hundred years. Since that time, curricula have expanded, but the persistent assumption has been that well-trained, conscientious clinicians will not make errors. Systems thinking, which explains how flawed structures, policies and processes lead to errors and harm, has not been a part of that training. By allowing this mindset to persist, we are setting up future clinicians to fail. If we want safer care, teaching about safety must play a more central role in medical education. In this paper, Albert Wu suggests that this should begin as early as possible, stretching back into pre-professional education and even grade school.

Generative artificial intelligence (AI) systems now summarise health-related search results, answer medical questions and offer guidance people once sought from clinicians. These systems bring real benefits, including plain-language explanations of medical information, around-the-clock availability and expanded access for people facing language or literacy barriers. They also carry new risks: inaccurate guidance can harm people at scale, and malicious actors can now generate personalised health misinformation at negligible cost. In this Perspective published in Nature, the authors argue that these risks are largely invisible to the institutions responsible for protecting public health. When AI guidance causes harm, no record exists outside the platform, no channel allows users to report it and no independent researcher can measure the consequences. The authors trace these invisible risks across two settings: incidental exposure online and active seeking through search engines and chatbots. Minimising harm from AI-generated health information requires making it observable. The authors therefore offer recommendations that aim to improve transparency, mitigate harm at the point of delivery and assign accountability, ranging from voluntary platform measures to regulatory ones.

Maternity wards across the United States are facing a wave of closures as cuts to federal Medicaid funding take effect, experts have warned. According to analysis by the non-profit Protect Our Care, 52 maternity wards have closed since the HR1 bill was announced in July 2025, with a further eight having announced their upcoming closure. The bill, which will fully come into effect in the new year, will result in many adults covered through Medicaid having to meet new work requirements and being subject to more frequent eligibility checks, while there will be less federal funding for states for Medicaid. Hospitals which have already permanently closed their maternity wards include the Centra Southside Community hospital in Virginia and St Mary’s Sacred Heart hospital in rural north-east Georgia, which both cited upcoming federal policy changes to Medicaid as a reason. Experts are expecting to see more closures of maternity units in the run-up to and after the federal changes to Medicaid come into effect in the new year. “We’re deeply concerned that these changes already have and will continue to worsen an already serious maternity care crisis,” said Erin Jones, senior director of legislative and strategic counsel of the non-profit March of Dimes. “Reduced funding and restrictions on how states finance Medicaid will put additional pressure on state budgets and hospitals, increasing the risk that communities lose essential maternity services and specialized providers close to home.” Read full story Source: The Guardian, 11 October 2026

Calls are continuing for a fresh investigation into the death of former UN peacekeeper Ryan Wallace. Scotland’s Patient Safety Commissioner, Karen Titchener, backs politicians who say lessons should be learned from Ryan’s death as the case raises questions about how patients with complex and unexplained illnesses are supported. The intervention comes amid growing criticism of NHS Forth Valley’s refusal to carry out a Significant Adverse Event Review ­following Ryan’s decision to end his life at a clinic in Switzerland on 18 August. NHS Forth Valley insists concern raised by Ryan and his family were investigated through its complaints ­process and later upheld by the Scottish Public Services Ombudsman. But his widow, Marianne Wallace, argues that investigation only examined events and concerns raised at that time. She said: “Their investigation did not examine the years that followed when Ryan’s health continued to deteriorate, he was given a succession of different diagnoses and treatment plans, and we felt forced to spent more than £60,000 on private healthcare as we searched for answers.” Scottish Conservative Shadow Health Secretary Miles Briggs last week called on the health board to commission an investigation voluntarily, despite there being no requirement to do so because Ryan died outside Scotland. Titchener said: “I can’t comment on the details of his care, and it isn’t my role to investigate this individual case, but his story raises questions. The whole system should want to understand what happens when someone lives for years with unexplained symptoms, conflicting diagnoses, and complex medication, and feels they need to look elsewhere for answers. “A complaint process tells us whether individual decisions were reasonable at the time. It doesn’t always tell us what we could learn from the whole journey. Learning shouldn’t stop because a complaint has been closed.” Read full story Source: The Sunday Post, 11 October 2026

A GP who entered incorrect data while completing death certifications will be suspended for 10 months, a fitness-to-practise tribunal has ruled. At the time of the events that led to the suspension, Dr Lea Cramsie was practising as a salaried GP for a practice in Glasgow which provided care to people living in nursing homes, according to documents released by the Medical Practitioners Tribunal Service (MPTS). The MPTS said that the allegations were related to Dr Cramsie completing medical certificates of cause of death and ticking the box to confirm the deaths had been reported to the procurator fiscal ‘when she knew they had not’; this would exclude the deaths from being selected for review by the Death Certification Review Service. The documents said that the allegations related to ‘31 occasions’. In Scotland, the procurator fiscal has a duty to investigate certain deaths, such as those which are sudden, suspicious, accidental or unexplained, with specific guidance for GPs on when a death should be reported. The initial concerns were raised with the GMC on 26 June this year by the deputy medical director for primary care for NHS Greater Glasgow and Clyde. The referral to the GMC was further to a local investigation by the health board which arose from ‘concerns that had been raised around death certificate completion’. The GMC acknowledged that Dr Cramsie had described herself as ‘dealing with what she considered to be a disproportionate workload of death certificates’. The regulator submitted that Dr Cramsie’s workload ‘might provide some explanation for the misconduct’, but that the evidence from other practice members did not suggest that the workload was considered ‘unusually onerous’. Read full story Source: Pulse, 9 October 2026

An ongoing potential corporate manslaughter investigation is looking into the deaths of four patients, a court has heard today. Police have been investigating allegations of neglect and mistreatment of patients on the stroke unit at Blackpool Victoria Hospital since 2018. Since then, two staff members have been jailed for poisoning patients, and a murder inquiry launched into the death of patient Valerie Kneale after a violent sexual assault. The investigation, known as Operation Bermuda, was also expanded to cover potential gross negligence or corporate manslaughter charges in 2023. In an update to Blackpool and Fylde coroner’s court, the patients were named as 86-year-old Margaret Mary Hamilton and Geoffrey Duckworth, 81-year-old Peter Whittaker, and 75-year-old Joan Walker. Detective chief inspector Mark Dickinson also told the court that the Care Quality Commission had investigated the deaths of the four patients but decided not to prosecute the trust. DCI Dickinson said Operation Bermuda was originally launched to investigate allegations that patients on the stroke ward were being sedated with the drug Zopiclone without any clinical need. DCI Dickinson said: “The investigation also identified other patients believed to have received poor care. Likewise, in the case of four patients, potential causal links were identified between the care they received and their death.” Read full story (paywalled) Source: HSJ, 9 October 2026

Risa Mallory is a retired psychotherapist from Canada and a hub Topic leader. After a serious cardiovascular event in 2018 she became a patient advocate, collaborating with organisations across the globe. In this blog, Risa says that when patients are listened to, respected, and engaged as partners, treatment adherence becomes about collaboration rather than compliance.

Lives could be saved and the public better protected against future epidemic and pandemic threats through a £33.2 million UK Government investment in vaccines against some of the world’s deadliest infectious diseases. This investment will help scientists to develop, test and deploy vaccines faster when new health threats emerge, both supporting people in low and middle-income countries (LMICs) and, in turn, protecting the UK by strengthening pandemic preparedness and improving resilience to future epidemic and pandemic threats. The programme has already demonstrated the value of investing, having supported development of the Oxford/AstraZeneca COVID-19 vaccine. This latest investment will help researchers respond more quickly to future threats. Supported by the UK Vaccine Network and delivered through Innovate UK, the funding will target diseases including Ebola, plague, Marburg, Lassa fever, Nipah virus, chikungunya and Mayaro. Eight projects will advance promising vaccines, clinical trials and technologies that can make vaccine design and manufacture faster and more effective. The new awards will build the research, clinical trial and technical capability needed to develop, test and deploy vaccines at speed. They will also help make vaccines affordable, accessible and ready for use in countries at greatest risk. Read full article. Source: Department of Health and Social Care, 8 October 2026

Along-awaited review aimed at identifying “systemic changes” to Scotland’s crisis-hit maternity services has begun. The nine month-long nationwide review will examine how care can be improved for women, babies, and families across the country. The independent review is being chaired by the maternal and child health expert, Professor Christine McCourt, who is expected to submit her findings and recommendations in July 2027. The Scottish government said the review will take a “whole-system approach,” drawing on data, evidence and the direct experiences of women, families and staff at every level of care. However, some bereaved families have voiced misgivings about the scope of the review, and warned that it was in danger of becoming an “absolute insult” as a result. Read full article. Source: The Scotsman, 5 October 2026

This report sets out the findings and recommendations of an independent review into prevalence and support for mental health conditions, ADHD and autism. The review, chaired by leading clinical psychologist Professor Peter Fonagy with the support of vice chairs Professor Sir Simon Wessely and Professor Gillian Baird, found that mental distress has increased substantially among children and young people. The findings show this has been driven by several factors, including social media, financial insecurity, increased uncertainty about the future, poorer sleep, and reduced feelings of connection and belonging. While referrals and diagnoses for ADHD and autism have risen significantly, the review found that population-level prevalence of these conditions appears broadly stable.

This Health Services Safety Investigation Body (HSSIB) learning resource is aimed at learners with roles in healthcare safety investigation, including investigation, commissioning, oversight and involvement. By the end of this resource, you will be able to: Understand why you would use SEIPS in an investigation. Explain the elements of the SEIPS framework in their relation to a patient safety event. Justify the use of SEIPS as part of a safety investigation.

This strategy sets out Spain's strategic framework for strengthening patient safety over the next decade, promoting safer healthcare systems, fostering a culture of safety, and advancing patient-centred care across all levels of the health system.

There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found. Experts said a rise in diagnoses over the past 25 years meant cases now appear to be outstripping the expected number in the population for some younger age groups. The review called for tougher regulation of private firms offering assessments for the NHS, saying they had concerns about quality and consistency, and a ban on advertising. It concluded economic uncertainty combined with social media was driving an increase in mental health problems among young people and said there needed to be better support in place for all conditions. It is likely to feed into government policies on everything from NHS services and benefits to support for young people who are not in education, employment or training. Read full article. Source: BBC News, 9 October 2026

The World Health Organization (WHO) and partners have launched a new global roadmap to tackle hypertensive disorders of pregnancy, including pre-eclampsia, which affect millions of women every year. These disorders remain among the leading causes of death and serious illness for pregnant women and their babies, with tragic long-term impact on their families. Hypertensive disorders complicate an estimated 10–15% of pregnancies worldwide. They account for around 16% of maternal deaths globally, resulting in an estimated 42 000 deaths each year, as well as more than 500 000 stillbirths and newborn deaths. In many countries, women still lack reliable access to basic blood-pressure measurement, urine protein testing and essential medicines, including aspirin, antihypertensives and magnesium sulfate. Weak referral systems, shortages of trained health workers and limited emergency obstetric services can further delay life-saving care. Launched at the Society for Maternal-Fetal Medicine Global Conference, the Global roadmap for hypertensive disorders of pregnancy from 2026 to 2035 and beyond sets out coordinated actions across research and innovation, global clinical guidance, access to medicines and diagnostics, implementation, advocacy and accountability. The roadmap highlights a striking innovation gap between the scale of the problem and the lack of medicines specifically developed and approved by regulators for the prevention or treatment of pre-eclampsia or eclampsia. Research investment has largely focused on diagnostics, with chronic underinvestment in new preventive and treatment options. Read full article. Source: World Health Organization, 8 October 2026

At least a fifth of baby deaths last year may have been preventable, with this estimate considered “a minimum”, an analysis of thousands of care reviews has concluded. The findings were set out in the latest annual report into 2025 Perinatal Mortality Review Tool investigations, published today by MBRRACE-UK. The report comes amid intense scrutiny of maternity services following the publication of the national maternity and neonatal investigation and Donna Ockenden’s Nottingham review this summer. Read full article (paywalled). Source: Health Service Journal, 9 October 2026